Verve Therapeutics Ratios and Metrics

Market cap in millions IDR. Fiscal year is January - December.

Millions IDR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '25 Aug 1, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	517,598	643,500	-	-	-
Enterprise Value	454,073	683,743	-	-	-
Last Close Price	156.00	196.45	-	-	-
PE Ratio	12.95	20.82	-	-	-
PS Ratio	2.16	3.11	-	-	-
PB Ratio	2.74	3.58	-	-	-
P/TBV Ratio	2.74	3.58	-	-	-
P/FCF Ratio	33.78	71.15	-	-	-
P/OCF Ratio	26.98	50.53	-	-	-
EV/Sales Ratio	1.89	3.30	-	-	-
EV/EBITDA Ratio	9.47	15.74	-	-	-
EV/EBIT Ratio	9.60	16.42	-	-	-
EV/FCF Ratio	29.64	75.60	-	-	-
Debt / Equity Ratio	0.00	0.10	0.56	1.59	1.55
Debt / EBITDA Ratio	0.01	0.43	1.67	2.89	2.11
Debt / FCF Ratio	0.05	2.06	-	-	10.05
Asset Turnover	-	0.96	0.83	1.18	-
Inventory Turnover	-	4.70	2.84	2.90	-
Quick Ratio	3.52	1.89	0.49	0.71	0.77
Current Ratio	6.33	3.67	1.44	1.53	1.58
Return on Equity (ROE)	-	24.59%	25.41%	43.89%	-
Return on Assets (ROA)	-	12.11%	9.28%	11.34%	-
Return on Capital (ROIC)	-	16.78%	14.36%	16.14%	-
Return on Capital Employed (ROCE)	24.40%	22.60%	29.30%	33.50%	34.40%
Earnings Yield	7.24%	4.80%	-	-	-
FCF Yield	2.96%	1.41%	-	-	-
Dividend Yield	1.92%	1.53%	-	-	-
Payout Ratio	-	-	-	46.91%	91.84%
Buyback Yield / Dilution	-12097.33%	-102.54%	-983.96%	-362.34%	-
Total Shareholder Return	-12095.44%	-101.01%	-983.96%	-362.34%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.